Aging: How Aging Works, How We Reverse Aging, and Prospects for Curing Aging Diseases
★★★★★
★★★★★
English
Aging: How Aging Works, How We Reverse Aging, and Prospects for Curing Aging Diseases explains the simplified wear-and-tear” of aging beyond entropy to expose it as a complicated process. With solid academic approach, this book builds upon the substantial work published over the past 16 years, citing the newest data, up-to-date models based upon that data, and implications for improved clinical care, including recent developments in gene and cell therapy. Coverage delves into age-related diseases, including neurodegenerative, cardiovascular, bone and joints, immune system, and skin. Future directions of the field are discussed among interventions where a summary of previous attempts to intervene in aging and age-related disease are discussed. This is the perfect reference for scientists and researchers interested in the basic translational research opportunities such as drug discovery, pharmacogenetics, and experimental therapeutics, as well as clinicians interested in how AI applications are integrated with applications to focus on digital pathology and personalized medicine.
See more
Current price
€125.99
Original price
€139.99
Save 10%
Will deliver when available. Publication date 29 Mar 2024
Product Details
Weight: 450g
Dimensions: 191 x 235mm
Publication Date: 29 Mar 2024
Publisher: Elsevier Science Publishing Co Inc
Publication City/Country: United States
Language: English
ISBN13: 9780443155000
About
Dr. Fossel has an MD and a PhD in neurobiology from Stanford University where he taught neurobiology and research methods. A clinical professor of medicine he is considered to be the world foremost expert on telomeres aging and age-related disease. He gave the first talk at the NIH on reversal of human aging published the first articles on the potential of telomeres as a clinical intervention and authored the first and only medical textbook in this field. He was editor-in-chief of Rejuvenation Research and the director of the American Aging Association and as well as the current Editor-in-Chief OBM Geriatrics. He has authored more than 100 books chapters and articles including The Telomerase Revolution which the Wall Street Journal praised as one of the best science books of the year. He is the president of Telocyte a biotech firm taking telomere therapy to FDA human trials. He has fulfilled numerous invitations to chair academic conferences and give opening keynotes.